Santa Fe, NM, United States of America

Jerry M Held

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vivus, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerry M Held. Retrieved from https://idiyas.com/inventor/jerry-m-held-8ytzkx91

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jerry M Held: Innovator in Pharmaceutical Treatments

Introduction

Jerry M Held is a notable inventor based in Santa Fe, NM (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel treatment methods for various conditions. His innovative approach combines different medications to enhance therapeutic outcomes.

Latest Patents

Jerry M Held holds 1 patent for his invention titled "Compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment." This invention relates to novel pharmaceutical methods aimed at treating neurodegenerative diseases and damaged skin. The compositions involve at least one phosphodiesterase-5 inhibitor combined with other medications, such as selective serotonin reuptake inhibitors and cholinesterase inhibitors, to improve treatment efficacy.

Career Highlights

Throughout his career, Jerry has been associated with Vivus, Inc., where he has focused on advancing pharmaceutical innovations. His work has contributed to the development of effective treatment options that address complex medical conditions.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Jerry M Held's contributions to pharmaceutical innovations demonstrate his commitment to improving treatment methods for various health conditions. His work continues to influence the field and offers hope for better therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…